Axsome Therapeutics is a biopharmaceutical company focused on central nervous system disorders. Its commercial portfolio includes Auvelity for major depressive disorder and Sunosi for excessive daytime sleepiness linked to narcolepsy or obstructive sleep apnea. The company develops and markets differentiated CNS medicines for patients whose needs are incompletely met by existing treatments.
| Quarter | Revenue | YoY % | Earnings | YoY % |
|---|---|---|---|---|
| Q1 2025 | 121.5 | — | -59.4 | — |
| Q2 2025 | 150 | — | -48 | — |
| Q3 2025 | 171 | — | -47.2 | — |
| Q4 2025 | 196 | — | -28.6 | — |
| Q1 2026 | 191.2 | 57.4% | -64.5 | — |
| Q2 2026 | 218.4 | 45.5% | -51.3 | — |
All markets — KeepWinning global stock screener
Other companies on Nasdaq: Viavi Solutions Inc. (VIAV), FormFactor, Inc. (FORM), Viasat, Inc. (VSAT), Columbia Banking System, Inc. (COLB), Central Bancompany, Inc. (CBC), Commerce Bancshares, Inc. (CBSH)